Patents by Inventor Olivier CAZORLA

Olivier CAZORLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MITOCHONDRIA-TARGETING ANTIOXIDANTS
    Publication number: 20220370394
    Abstract: The present invention relates to compounds having a lipid affinity of less than 15% by weight of the compound (such as a log P of ?0.75 or less) for use in targeting mitochondria to reduce, inhibit or prevent the formation of mitochondrial reactive oxygen species and for use in treating or preventing a pathological condition associated with increased levels of mitochondrial reactive oxygen species, and for non-therapeutic uses, such as enhancing sports performance and reducing, inhibiting or preventing the formation of mitochondrial reactive oxygen species during exercise, resulting in maintenance of muscle strength and/or a reduction in muscle fatigue, and associated methods. The present invention also relates to extracts and compositions comprising compounds having a lipid affinity of less than 15% (such as a log P of ?0.75 or less) for the same uses.
    Type: Application
    Filed: November 6, 2020
    Publication date: November 24, 2022
    Inventors: Doria BOULGHOBRA, Michael LAGUERRE, Mathieu TENON, Jérémy FAUCONNIER, Simona BIRTIC, Pascale Elizabeth Renée FANÇA-BERTHON, Cyril REBOUL, Olivier CAZORLA
  • Methods for treating myocardial infarction comprising administering sonic hedgehog
    Patent number: 9987327
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: June 5, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, ASSITANCE PUBLIQUE—HOPITAUX DE PARIS, UNIVERSITE PARIS EST CRETEIL VAL DE MARNE, UNIVERSITE D'ANGERS
    Inventors: Alain Lacampagne, Jerome Thireau, Olivier Cazorla, Jean-Yves Le Guennec, Jeremy Fauconnier, Maria del Carmen Martinez, Ramaroson Andriantsitohaina, Bijan Ghaleh-Marzban, Raffaella Soleti
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE CARDIOPROTECTION
    Publication number: 20170049854
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Application
    Filed: October 17, 2016
    Publication date: February 23, 2017
    Inventors: Alain LACAMPAGNE, Jerome THIREAU, Olivier CAZORLA, Jean-Yves LE GUENNEC, Jeremy FAUCONNIER, Maria del Carmen MARTINEZ, Ramaroson ANDRIANTSITOHAINA, Bijan GHALEH-MARZBAN, Raffaella SOLETI
  • Methods for treating myocardial infarction comprising administering sonic hedgehog
    Patent number: 9504732
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: November 29, 2016
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE PARIS EST CRETEIL VAL DE MARNE
    Inventors: Alain Lacampagne, Jerome Thireau, Olivier Cazorla, Jean-Yves Le Guennec, Jeremy Fauconnier, Maria del Carmen Martinez, Ramaroson Andriantsitohaina, Bijan Ghaleh-Marzban, Raffaella Soleti
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE CARDIOPROTECTION
    Publication number: 20150352182
    Abstract: The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
    Type: Application
    Filed: January 14, 2014
    Publication date: December 10, 2015
    Inventors: Alain LACAMPAGNE, Jerome THIREAU, Olivier CAZORLA, Jean-Yves LE GUENNEC, Jeremy FAUCONNIER, Maria del Carmen MARTINEZ, Ramaroson ANDRIANTSITOHAINA, Bijan GHALEH-MARZBAN, Raffaella SOLETI